SCHEMBL6162358

SCHEMBL6162358

COc1cccc(OC)c1-c1nn(CCO)c2c1C(=O)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
POLL Q9UGP5 1/20 0.40
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
TOP1 P11387 1/20 0.35
PEX14 O75381 5/20 0.34
EP300 Q09472 1/20 0.33
CREBBP Q92793 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
HTR2C P28335 1/20 0.33
CTSS P25774 1/20 0.33
PIK3CD O00329 1/20 0.33
ABL1 P00519 1/20 0.33
EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164169 0.78 HTT (0.48) HTTKDM4EALDH1A1CREBBPMEN1
SCHEMBL6166822 0.74 HTT (0.44) HTTKDM4EALDH1A1GAACREBBP
SCHEMBL6164980 0.72 HTT (0.44) HTT
SCHEMBL6166773 0.66 HTT (0.52) HTT
SCHEMBL6166178 0.66 SIK2 (0.33) ALDH1A1GAAHTR2CMAPTCA1
SCHEMBL6166246 0.65 HTT (0.42) HTTKDM4EMEN1KMT2A
SCHEMBL6166242 0.65 HTT (0.42) HTTKDM4EMEN1KMT2A
SCHEMBL8736314 0.64 ALDH1A1 (0.56) HTTPOLLKDM4EALDH1A1GLA
SCHEMBL266254 0.64 KDM4E (0.56) POLLKDM4EALDH1A1GLAGAA
SCHEMBL6165167 0.64 HTT (1.00) HTTALDH1A1CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed